Growth Rates measured twice weekly after treatment initiation (A).

<p>Tumor sizes at the end of the experiment were 122.33+/−105.86 mm² (mean +/− SD) in the control group, 76.73+/−36.09 mm² in tumors treated with SGK-1 inhibitor, 94.52+/−75.92 mm² in the Cisplatin group, and 25.76+/−14.89 mm² with combination of local SGK-1 inhibition and systemic cisplatin. Black arrows indicate timing of systemic cisplatin-, and blue arrows timing of SGK-1 Inhibitor application. Repeated measures ANOVA for growth rates (<b>B</b>). Newman-Keuls Multiple Comparison Test for growth rates; df = degrees of freedom, Sig. = Significance; Diff. = Difference, q = studentized range value, ** = p<0.001; *** = p<0.0001 (<b>C</b>).